Company news

Recursion Pharmaceuticals, Inc. news in 2026

Recursion Pharmaceuticals, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Recursion Reports Third Quarter 2026 Financial Results and Extends Cash Runway; Highlights Positive Clinical Data in REC-4881 and REC-1245, Sanofi Development Candidate Option and Appointment of Fred Hassan as Chair

November 2, 2026

Recursion Appoints Fred Hassan as Chair of the Board

November 2, 2026

Recursion to Host Webinar Focused on Updated REC-4881 (FAP) Data from CGA-IGC on Tuesday, November 3

October 26, 2026

Recursion Announces Sanofi Options Potential First-in-Class Immunology Development Candidate from Their Collaboration

October 15, 2026

Recursion Announces Pricing of $200 Million Underwritten Offering of Class A Common Stock

October 15, 2026

Recursion Announces $200 Million Oversubscribed Follow-On Offering, Clinical Data Updates, and Partnership Milestone

October 15, 2026

Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program

August 5, 2026

Recursion to Report Second Quarter 2026 Business Updates and Financial Results on August 5th

July 29, 2026

Remix Therapeutics to Present at AACR Drug Discovery and Development Conference

July 16, 2026

Recursion Reports First Quarter Financial Results and Provides Business Update

May 6, 2026

Recursion Announces Board Transition

April 30, 2026

Recursion to Report First Quarter 2026 Business Updates and Financial Results on May 6

April 28, 2026

Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform

March 31, 2026

Recursion Announces Vicki Goodman, M.D., as Incoming Chief Medical Officer

March 24, 2026

PacBio Announces the Appointment of Chris Gibson to the Board of Directors

March 5, 2026

Recursion Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

February 25, 2026

Recursion To Be Featured in HighRes’ Lightning Talk at NVIDIA GTC

February 23, 2026

Recursion to Report Fourth Quarter and Full Year 2025 Business Updates and Financial Results on February 25

February 18, 2026

Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules

February 12, 2026

Recursion to Present at 44th Annual J.P. Morgan Healthcare Conference

January 5, 2026

Calls in 2026

Decks in 2026